Subscribe to our press releases
ChromoGenics has reached sales targets for first quarter 2019
ChromoGenics has previously communicated a turnover of 80 MSEK for 2019. During first quarter a sales volume of about 25% of the turnover target for the year has been reached which is in line with the the internal sales plan.
“We are satisfied to have reached our sales targets for Q1-2019. We will continue to work hard in the marketplace to also reach the targets for the remaining of 2019, says CEO Jerker Lundgren.
Jerker Lundgren, CEO
Lars Ericsson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
Certified Adviser: G&W Fondkommission, e-mail: email@example.com, tel.: +46 (0) 8 503 000 50
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
ChromoGenics offers dynamic glass with controllable heat- and light transmission and static glass with world leading performance. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.